Carriers for the delivery of a vaccine against respiratory syncytial virus.

about

Carriers for the delivery of a vaccine against respiratory syncytial virus.

Item

http://www.wikidata.org/entity/Q36194078

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Carriers for the delivery of a vaccine against respiratory syncytial virus.

@ast

Carriers for the delivery of a vaccine against respiratory syncytial virus.

@en

type

Item

label

Carriers for the delivery of a vaccine against respiratory syncytial virus.

@ast

Carriers for the delivery of a vaccine against respiratory syncytial virus.

@en

prefLabel

Carriers for the delivery of a vaccine against respiratory syncytial virus.

@ast

Carriers for the delivery of a vaccine against respiratory syncytial virus.

@en

P1476

Carriers for the delivery of a vaccine against respiratory syncytial virus.

@en

P2093

Geraldine Taylor

http://www.w3.org/2001/XMLSchema#string

Martin Cranage

http://www.w3.org/2001/XMLSchema#string

P2860

Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells

Mortality associated with influenza and respiratory syncytial virus in the United States

Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.

Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine

Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.

Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge.

Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells.

Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice.

Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.

P304

939-952

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.5.7.939

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16018739

http://www.w3.org/2001/XMLSchema#string